drugset / Trial / NCT02860065
CPC-201 Alzheimer's Disease Type Dementia: PET Study
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the effect of low and high dose CPC-201 on brain function including cerebral acetylcholinesterase (AChE) activity measured by positron emission tomography (PET).
Timeline
- Start
- 2016-09-30
- Primary completion
- 2017-06-30
- Completion
- 2017-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donepezil | Small molecule | 50 mg | — |
| Subject | Solifenacin | Small molecule | 15 mg | — |